Plaque
psoriasis is a chronic skin disease, long-lasting autoimmune disease
characterized by patched of abnormal skin. Plaque psoriasis is most common
disease and it is also known as psoriasis vulgaris. Moreover, it can be appear
anywhere on a human body but most often found in elbows, lower back, scalp,
knees. Plaque psoriasis is associated with other serious health conditions,
such as heart disease, depression and diabetes. In some cases it is observed
that psoriasis is burns, stings, red, scaly and itchy. Whereas, people with
darker skin the patches may be purple in color. Additionally, there are five
types of psoriasis which includes plaque, pustular, erythrodermic, inverse and
guttate. Psoriasis is not contagious but infections and psychological stress can
play a significant role which makes the plaque psoriasis worsen. As the disease
trigger psoriatic skin changes, the more research and development is done for
the better treatment which lead the significant market growth globally.
According
to the report analysis, ‘Plaque
Psoriasis (Psoriasis Vulgaris) Global Clinical Trials Review, H1, 2018’ suggests that some of the major companies
and healthcare organizations which are currently functioning in this market by
folding up their sleeves with the upgraded technology includes LEO Foundation,
Novartis AG, Johnson & Johnson, AbbVie Inc, Pfizer Inc, Eli Lilly and Co,
Amgen inc, Celgene Corp, Astellas Pharma Inc, GlaxoSmithKline Plc, Merck &
co., Inc., Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche
Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc.,
Ge Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc.,
National Cancer Center, The University of Texas M. D. Anderson Cancer Center,
Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer
Research UK, North Central Cancer Group, Fred Hutchinson Cancer Research
Center, European Organization for Research and Treatment of Cancer, Dana-Farber
Cancer Institute, Columbia University, Mayo Clinic, Duke University, Ohio State
University, University of Pennsylvania and others. Moreover, with the more
development in the technology and new innovations in the setup strategies &
policies more healthcare organizations are going to be established in the
market which will lead to the significant growth in the vaccine market.
Dry,
cracked skin that may bleed, swollen and stiff joints, itching, burning or
soreness, red patched of skin covered with thick, silvery scales, small scaling
spots are the most common signs and symptoms of psoriasis whereas, the sign and
symptoms are different for everyone. Basically, there is no proper cure for the
psoriasis but the symptoms can be treated with some of the antibiotics which
are prescribed by the doctor. Geographically, the vaccine market for the
psoriasis has been spread across the globe which includes Asia-Pacific region,
Europe, North America, Middle East and Africa, Central and South America.
Additionally, it is also expected that in 2018 the vaccine market of psoriasis
is going to grow even more with upgradation in the old units and research and
development. Furthermore new innovations in the vaccine market result to
competition and welcome the new entrants which make the market more profitable
and provide the financial support. Therefore, the vaccine market of the
psoriasis vulgaris is expected to grow more in the coming years.
To know
more, click on the link below:
Contact
Us:
Ken Research
Ankur Gupta, Head Marketing &
Communications
+91-9015378249